Natixis Advisors LLC Acquires New Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

Natixis Advisors LLC acquired a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 17,721 shares of the company’s stock, valued at approximately $232,000.

Other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp grew its holdings in shares of Pediatrix Medical Group by 1.4% in the third quarter. State Street Corp now owns 3,540,791 shares of the company’s stock worth $41,038,000 after purchasing an additional 50,597 shares during the last quarter. Pacer Advisors Inc. bought a new stake in Pediatrix Medical Group during the fourth quarter worth about $35,492,000. Geode Capital Management LLC raised its stake in Pediatrix Medical Group by 2.4% during the third quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company’s stock valued at $22,452,000 after buying an additional 45,155 shares during the last quarter. Weiss Asset Management LP grew its position in Pediatrix Medical Group by 50.5% during the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock valued at $10,580,000 after purchasing an additional 306,143 shares during the last quarter. Finally, ArrowMark Colorado Holdings LLC grew its holdings in shares of Pediatrix Medical Group by 3.8% during the third quarter. ArrowMark Colorado Holdings LLC now owns 787,649 shares of the company’s stock valued at $9,129,000 after buying an additional 28,804 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Down 5.8 %

Shares of NYSE MD opened at $14.15 on Friday. The stock has a market capitalization of $1.21 billion, a price-to-earnings ratio of -11.79, a P/E/G ratio of 1.74 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The firm’s 50-day moving average price is $14.40 and its 200-day moving average price is $13.65. Pediatrix Medical Group, Inc. has a 12-month low of $6.62 and a 12-month high of $17.67.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The business had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. On average, equities research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on MD shares. UBS Group raised their target price on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a report on Friday, February 21st. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Truist Financial lifted their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, February 21st. Finally, Macquarie initiated coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 price target on the stock. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.